The real-world evidence of heart failure co-morbiditiesdoi:10.1002/ejhf.751AlanMemorialCarePanMemorialCareWileyEuropean Journal of Heart Failure
heart failure 【医】 心力衰竭 soft failure 软性故障 evidence n. 1.[U] 证据;证词;证人;物证(+of/for)[+that][+to-v] 2.[U,C] 迹象(+of)](+that) 3.[U] 清楚,明显 v. [T] 1. 证明 self evidence [ self-evident ]的相关名词 counter evidence n. 反证 AI (abbr. = artificial...
Heart failure (HF) with preserved ejection fraction (EF; HFpEF) is a clinical entity characterized by symptoms of HF despite a “preserved” (i.e. 50%) left ventricular (LV) ejection fraction (LVEF) with evidence of cardiac dysfunction as a primary cause of symptoms (eg, abnormal LV fillin...
Such patients are likely to be older with more comorbid disease and are more likely to present with evidence of heart failure and abrupt chest pain and have arch involvement (104). Although a continued attrition rate is recognized, there is perhaps sufficient time to undertake additional ...
Systematic review of fluid restriction for treatment of heart failure: What is the evidence?Y., WangS.H., Gottlieb
Heart Failure Reviews(2024) Effects of renal denervation on kidney function in patients with chronic kidney disease: a systematic review and meta-analysis Ahmed A. Mohammad Khaled Nawar Mohammed H. Abdulla Journal of Human Hypertension(2023) ...
Heart failure (HF) is a complex clinical syndrome characterized by the activation of at least several neurohumoral pathways that have a common role in maintaining cardiac output and adequate perfusion pressure of target organs and tissues. The sympathetic nervous system (SNS) is upregulated in HF ...
V. et al. Heart rate variability and progression of coronary atherosclerosis. Arter. Thromb. Vasc. Biol. 19, 1979–1985 (1999). Article CAS Google Scholar van Bilsen, M. et al. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the...
37% risk reduction for progression to symptomatic heart failure can be achieved with ACE-inhibition in asymptomatic patients with systolic left ventricular dysfunction (55). Thus, ACE-inhibition should be part of standard treatment in symptomatic and asymptomatic patients with left ventricular dysfunction...
Heart failure (HF) is a chronic, progressive, and ultimately lethal disease that affects >6 million American adults, with an additional 870,000 individuals diagnosed annually (1). Despite advances in HF therapies, nearly 40% of patients will die within a year of their first hospitalization (2...